{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:09:17Z","timestamp":1793725757605,"version":"4.6.1"},"reference-count":35,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,5,8]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Compared with parous female sibling donors, male URDs confer more aGVHD in all patients and more cGVHD in females. There was no difference in survival, relapse, or transplant mortality between recipients of parous female sibling or male URD grafts.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017013052","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T16:00:16Z","timestamp":1525795216000},"page":"1022-1031","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":21,"title":["Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants"],"prefix":"10.1182","volume":"2","author":[{"given":"Anita J.","family":"Kumar","sequence":"first","affiliation":[{"name":"Tufts Medical Center, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoung","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Department of Medicine, and"},{"name":"Institute for Health and Society, Department of Biostatistics, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Hemmer","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukta","family":"Arora","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Spellman","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, National Marrow Donor Program\/Be The Match, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Pidala","sequence":"additional","affiliation":[{"name":"Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Couriel","sequence":"additional","affiliation":[{"name":"Utah Blood and Marrow Transplant Program, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin M.","family":"Alousi","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud D.","family":"Aljurf","sequence":"additional","affiliation":[{"name":"Department of Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Cahn","sequence":"additional","affiliation":[{"name":"Department of Hematology, Centre Hospitalier Universitaire de Grenoble, Grenoble, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell S.","family":"Cairo","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey S.","family":"Cutler","sequence":"additional","affiliation":[{"name":"Center for Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shatha","family":"Farhan","sequence":"additional","affiliation":[{"name":"Henry Ford Hospital Bone Marrow Transplant Program, Wayne State University, Detroit, MI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usama","family":"Gergis","sequence":"additional","affiliation":[{"name":"Hematolgic Malignancies & Bone Marrow Transplant, Department of Medical Oncology, New York Presbyterian Hospital\/Weill Cornell Medical Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Hale","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Johns Hopkins All Children's Hospital, St. Petersburg, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrukh K.","family":"Hashmi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Inamoto","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rammurti T.","family":"Kamble","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Kharfan-Dabaja","sequence":"additional","affiliation":[{"name":"Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret L.","family":"MacMillan","sequence":"additional","affiliation":[{"name":"University of Minnesota Blood and Marrow Transplant Program, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Marks","sequence":"additional","affiliation":[{"name":"Adult Bone Marrow Transplant, University Hospitals Bristol National Health Service Trust, Bristol, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[{"name":"Jichi Medical University, Shimotsuke, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Norkin","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, University Florida College of Medicine, Gainesville, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna","family":"Qayed","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olle","family":"Ringden","sequence":"additional","affiliation":[{"name":"Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry C.","family":"Schouten","sequence":"additional","affiliation":[{"name":"Department of Hematology, Academische Ziekenhuis, Maastricht, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk R.","family":"Schultz","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology, Oncology and Bone Marrow Transplant, British Columbia's Children's Hospital, The University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melhem M.","family":"Solh","sequence":"additional","affiliation":[{"name":"The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Teshima","sequence":"additional","affiliation":[{"name":"Kyushu University Hospital, Sapporo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Urbano-Ispizua","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Clinic, University of Barcelona, Institut d\u2019investigacions Biomediques August Pi i Sunyer, and Institute of Research Josep Carreras, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo F.","family":"Verdonck","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Isala Clinic, Zwolle, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Peter","family":"Gale","sequence":"additional","affiliation":[{"name":"Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty K.","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navneet S.","family":"Majhail","sequence":"additional","affiliation":[{"name":"Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison W.","family":"Loren","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"issue":"4","key":"2019111616520163900_B1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1537-2995.2008.02043.x","article-title":"Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies","volume":"49","author":"Kanda","year":"2009","journal-title":"Transfusion"},{"issue":"2","key":"2019111616520163900_B2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","article-title":"The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy","volume":"127","author":"Kollman","year":"2016","journal-title":"Blood"},{"issue":"19","key":"2019111616520163900_B3","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1182\/blood-2013-05-499830","article-title":"CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT","volume":"122","author":"Schmidt-Hieber","year":"2013","journal-title":"Blood"},{"issue":"11","key":"2019111616520163900_B4","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1182\/blood-2010-04-278317","article-title":"Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis","volume":"116","author":"Gupta","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2019111616520163900_B5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bbmt.2007.01.073","article-title":"Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia","volume":"13","author":"Moore","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2019111616520163900_B6","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/bmt.2013.50","article-title":"Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDS","volume":"48","author":"Robin","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"17","key":"2019111616520163900_B7","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1182\/blood-2011-09-381699","article-title":"Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia","volume":"119","author":"Saber","year":"2012","journal-title":"Blood"},{"issue":"32","key":"2019111616520163900_B8","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1200\/JCO.2007.15.5184","article-title":"Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group","volume":"26","author":"Schetelig","year":"2008","journal-title":"J Clin Oncol"},{"key":"2019111616520163900_B9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13045-016-0321-y","article-title":"Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study","volume":"9","author":"Ruggeri","year":"2016","journal-title":"J Hematol Oncol"},{"key":"2019111616520163900_B10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13045-017-0498-8","article-title":"Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT","volume":"10","author":"Brissot","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"2","key":"2019111616520163900_B11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbmt.2014.10.030","article-title":"Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type","volume":"21","author":"Warlick","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2019111616520163900_B12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3324\/haematol.2013.089979","article-title":"Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related\/unrelated donors","volume":"99","author":"Servais","year":"2014","journal-title":"Haematologica"},{"issue":"11","key":"2019111616520163900_B13","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1182\/blood-2013-04-496778","article-title":"Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS)","volume":"122","author":"Saber","year":"2013","journal-title":"Blood"},{"issue":"36","key":"2019111616520163900_B14","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1200\/JCO.2006.08.0952","article-title":"Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10\/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy","volume":"24","author":"Yakoub-Agha","year":"2006","journal-title":"J Clin Oncol"},{"issue":"8","key":"2019111616520163900_B15","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.bmt.1701423","article-title":"Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis","volume":"22","author":"Carlens","year":"1998","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2019111616520163900_B16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2141.1987.tb06160.x","article-title":"Risk factors for acute graft-versus-host disease","volume":"67","author":"Gale","year":"1987","journal-title":"Br J Haematol"},{"issue":"10","key":"2019111616520163900_B17","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3324\/haematol.2016.147645","article-title":"Donor and recipient sex in allogeneic stem cell transplantation: what really matters","volume":"101","author":"Kim","year":"2016","journal-title":"Haematologica"},{"issue":"7","key":"2019111616520163900_B18","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V80.7.1838.1838","article-title":"Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate","volume":"80","author":"Nash","year":"1992","journal-title":"Blood"},{"issue":"4","key":"2019111616520163900_B19","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2141.1990.tb06340.x","article-title":"Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation","volume":"74","author":"Flowers","year":"1990","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111616520163900_B20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bbmt.2014.12.018","article-title":"Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?","volume":"21","author":"Kongtim","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2019111616520163900_B21","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbmt.2006.03.015","article-title":"Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Loren","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2019111616520163900_B22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood-2003-07-2603","article-title":"Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants","volume":"103","author":"Randolph","year":"2004","journal-title":"Blood"},{"issue":"12","key":"2019111616520163900_B23","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/bbmt.2002.v8.abbmt080674","article-title":"Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"8","author":"Remberger","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"issue":"13","key":"2019111616520163900_B24","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","article-title":"High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation","volume":"110","author":"Lee","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2019111616520163900_B25","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111616520163900_B26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood.V100.2.406","article-title":"Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse","volume":"100","author":"Lee","year":"2002","journal-title":"Blood"},{"issue":"2","key":"2019111616520163900_B27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"issue":"8","key":"2019111616520163900_B28","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3324\/haematol.2011.054841","article-title":"Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups","volume":"97","author":"Bacigalupo","year":"2012","journal-title":"Haematologica"},{"issue":"7","key":"2019111616520163900_B29","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2004-09-3660","article-title":"Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission","volume":"105","author":"Miklos","year":"2005","journal-title":"Blood"},{"issue":"7996","key":"2019111616520163900_B30","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0140-6736(76)91727-X","article-title":"Alloimmunity to human H-Y","volume":"2","author":"Goulmy","year":"1976","journal-title":"Lancet"},{"issue":"20","key":"2019111616520163900_B31","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1002\/cncr.24531","article-title":"Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis","volume":"115","author":"Gratwohl","year":"2009","journal-title":"Cancer"},{"issue":"2, suppl","key":"2019111616520163900_B32","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.1016\/j.bbmt.2014.11.447","article-title":"Impact of gender: female matched related donor versus male matched unrelated donor on peripheral blood allogeneic stem cell transplant for male recipients [abstract]","volume":"21","author":"Farham","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"2019111616520163900_B33","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJMoa1200503","article-title":"HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1","volume":"367","author":"Venstrom","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"2019111616520163900_B34","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1182\/blood-2005-04-1614","article-title":"Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation","volume":"106","author":"Pavletic","year":"2005","journal-title":"Blood"},{"issue":"9487","key":"2019111616520163900_B35","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(05)66996-6","article-title":"Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial","volume":"366","author":"Wagner","year":"2005","journal-title":"Lancet"}],"updated-by":[{"DOI":"10.1182\/bloodadvances.2018021402","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T00:00:00Z","timestamp":1528761600000}}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/9\/1022\/880873\/advances013052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/9\/1022\/880873\/advances013052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T21:52:23Z","timestamp":1573941143000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/9\/1022\/15829\/Graftversushost-disease-in-recipients-of-male"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,5,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017013052","relation":{"erratum":[{"id-type":"doi","id":"10.1182\/bloodadvances.2018021402","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]}}}